α-Amino-β-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1-Reference-Cited by-同舟云学术

α-Amino-β-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1

Published:2001-10 Issue:20 Volume:11 Page:2719-2722
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Becker Daniel P,Barta Thomas E,Bedell Louis,DeCrescenzo Gary,Freskos John,Getman Daniel P,Hockerman Susan L,Li Madeleine,Mehta Pramod,Mischke Brent,Munie Grace E,Swearingen Craig,Villamil Clara I

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference22 articles.

1. Metalloproteinase inhibitors: new opportunities for the treatment of rheumatoid arthritis and osteoarthritis

2. For an excellent collection of current articles on MMP, see: Greenwald, R. A., Zucker, S., Golub, L. M., Eds. Inhibition of Matrix Metalloproteinases: Therapeutic Applications; Annals of the New York Academy of Sciences: New York, 1999; Vol 878. This volume comprises the collected proceedings of the conference of the same name held on Oct 21–24, 1998 in Tampa, FL, USA.

3. The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lanthanoids in Hydroarylaminations: Yb(III)- and Tb(III)-Catalyzed Addition of Arylamines to Activated Olefins;Synthesis;2024-03-06

2. An iron-catalyzed multicomponent reaction of cycloketone oxime esters, alkenes, DABCO·(SO₂)₂ and trimethylsilyl azide;Organic Chemistry Frontiers;2022

3. Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies;European Journal of Medicinal Chemistry;2021-11

4. Asymmetric Synthesis of α‐Difluorinated β‐Amino Sulfones through Detrifluoroacetylative Mannich Reactions;European Journal of Organic Chemistry;2021-06

5. Challenges with matrix metalloproteinase inhibition and future drug discovery avenues;Expert Opinion on Drug Discovery;2020-09-14